The need for evidence-based, non-drug medicine
- PMID: 22909920
- DOI: 10.1515/ijamh.2012.017
The need for evidence-based, non-drug medicine
Abstract
Evidence-based medicine (EBM) is defined as "the integration of best research evidence with clinical expertise and patient values." EBM is based on three equally important key factors: i) the best available scientific evidence; ii) the physician's experience and intuition; and, iii) the preferences and values of the patient. EBM uses a hierarchy of evidence and critical appraisal of the sources, which makes it possible to balance high quality evidence with documented effectiveness. A treatment that is more safe and effective, but less well documented may very well be the treatment of choice. Ethics (not putting the patient at risk of harm with a treatment if this can be avoided at all) is an important part of EBM. Many pharmaceutical drugs have a number needed to treat (NNT) of approximately 20 [NNT=20, confidence interval CI (5-50)] and the number needed to harm is less well understood and documented. The adverse effect profile of pharmacological agents can be more harmful than non-drug medicine. Most EBM-treatments are likely to be non-drug treatments in the future. There are six steps to the practice of EBM: i) the patients and the physician must work together to define the problem; ii) the patients and the physician must explore the patient's values and preferences; iii) the information about the possible alternative medical interventions must be discussed and critically appraised; iv) the best, relevant evidence must be applied to the patient as a treatment or cure; v) together, the patient and the physician must evaluate how useful the intervention was; and vi) if the intervention did not help sufficiently, the process must begin again. In this review, we explain, in our opinion, how non-drug EBM should be practiced.
Similar articles
-
Linking evidence-based medicine therapeutic summary measures to clinical decision analysis.MedGenMed. 2000 Jan 13;2(1):E6. MedGenMed. 2000. PMID: 11104452
-
[Procedures and methods of benefit assessments for medicines in Germany].Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. Dtsch Med Wochenschr. 2008. PMID: 19034813 German.
-
Procedures and methods of benefit assessments for medicines in Germany.Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5. Eur J Health Econ. 2008. PMID: 18987905
-
Evidence-based medicine in treatment and rehabilitation of spinal cord injured.Spinal Cord. 2005 Oct;43(10):587-92. doi: 10.1038/sj.sc.3101815. Spinal Cord. 2005. PMID: 16205649 Review.
-
[Choosing between different treatment options: how should I inform my patients?].Ned Tijdschr Geneeskd. 2009;153:B344. Ned Tijdschr Geneeskd. 2009. PMID: 19785821 Review. Dutch.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical